Expression of Interest

The Mood Food Company Pty Ltd

The Mood Food Company Pty Ltd (In Liquidation)

ABN 70 642 633 841

Closed

Sale of Assets

Barry Wight and Matt Sweeny, Liquidators of The Mood Food Company Pty Ltd (In Liquidation), are seeking immediate expressions of interest for the acquisition of the company's assets.

The Mood Food Company is an Australian functional food brand that creates snacks formulated to support mental wellbeing, mood, energy and cognitive health using science-backed natural ingredients.

Key highlights

Key investment highlights:

Industry recognition and momentum

  • Founded in 2021, The Mood Food Company is Australia’s only functional snack food brand dedicated to mental and cognitive wellbeing.
  • 2022: Winner of Best New Brand (Naturally Good Awards) and Best Gluten-Free Snack (Healthy Food Guide Awards).
  • 2023: Winner of Best Gluten-Free Chocolate Covered Snack and Best Australian-Made Natural Fruit-Based Snack Brand (Australian Made Awards).

Early market traction and retail penetration

  • Achieved national ranging in over 300 Woolworths storeswithin five months of launch.
  • Stocked in Costco Australia since October 2023, with two products currently being sold in-store.
  • Successfully ranged in Costco Japan in FY24, creating a pathway for expansion across the global Costco network.
  • One of the only health and functional brands with confirmed ranging in Coles’ confectionery category (from July 2026) and Aldi (January 2027).

Strong growth pipeline

  • Two products currently sold through major retail channels (Coles and Costco), with a further six products available for sale through the business’s rapidly growing ecommerce channel
  • Expansion opportunities beyond health food aisle to high-traffic mainstream aisles - where the majority of consumers shop.
  • Active export pipeline targeting key global markets, accelerated by Costco’s international footprint
  • The company’s direct-to-consumer channel has grown more than 600% since FY24 and presents a significant opportunity to accelerate further with targeted investment.

Innovative and defensible IP

  • Trademarks, health claims and IP owned by the company, with domestic and international protection.
  • Products utilise natural nootropics, enabling global scalability without the regulatory hurdles linked to synthetic alternatives and non-conforming ingredients

Secure supply chain

  • Relationship with reputable and reliable contract manufacturer
  • Ingredients used readily available on global commodities markets ensuring ongoing continuity of supply

Express your interest

Expressions of interest are to be submitted urgently and no later than Friday 9 October.

Relevant further information will be provided once a Confidentiality Agreement is signed.